Bixiye
P3-17 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2017
Natiijooyinka Raadinta
Soo bandhiga 2641 - 2650 ee natiijooyinka 4229
Bixiye
P15-17 Change to Administration of Interpreter Services for MHCP Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2017
Bixiye
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2017
Bixiye
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2016
Bixiye
P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2016
Bixiye
QP92-24 Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP91-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024
Bixiye
QP90-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024